The US Food and Drug Administration (FDA) has issued a final rule intended to ensure patients are better informed about their breast tissue density when undergoing mammography. The rule updates regulations first issued in the 1990s under the Mammography Quality Standards Act to oversee mammography facilities and improve breast cancer testing.
“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” said Hilary Marston, FDA’s chief medical officer in a press release on 9 March. “Since 1992, the FDA has worked to ensure patients have access to quality mammography.”
“The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards,” she added. “This means that more women have access to consistent, quality mammography.”…
